Detalles de la búsqueda
1.
Acetyl-CoA carboxylase 1 depletion suppresses de novo fatty acid synthesis and mitochondrial ß-oxidation in castration-resistant prostate cancer cells.
J Biol Chem
; 299(1): 102720, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36410440
2.
Arginase 2 is a Diagnostic and Prognostic Marker for Prostate Cancer and Is Associated with Metabolism.
Altern Ther Health Med
; 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581330
3.
DCUN1D1 promotes tumour progress in prostate cancer and its effect on DU145 in vitro.
J Pak Med Assoc
; 71(2(A)): 473-478, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33819231
4.
Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer.
BMC Cancer
; 20(1): 289, 2020 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32252682
5.
KIF4A: A potential biomarker for prediction and prognostic of prostate cancer.
Clin Invest Med
; 43(3): E49-59, 2020 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32971585
6.
Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Mol Cancer
; 18(1): 122, 2019 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31387585
7.
Expression of PD-L1 in tumor-associated nerves correlates with reduced CD8+ tumor-associated lymphocytes and poor prognosis in prostate cancer.
Int J Cancer
; 144(12): 3099-3110, 2019 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30537104
8.
Proposal of a Nomogram for Predicting Survival in Patients with Siewert Type II Adenocarcinoma of the Esophagogastric Junction After Preoperative Radiation.
Ann Surg Oncol
; 26(5): 1292-1300, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30805805
9.
Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Mol Cancer
; 22(1): 56, 2023 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36941584
10.
Metastatic prostate cancer-associated P62 inhibits autophagy flux and promotes epithelial to mesenchymal transition by sustaining the level of HDAC6.
Prostate
; 78(6): 426-434, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29383752
11.
BACH1 promotes the progression of human colorectal cancer through BACH1/CXCR4 pathway.
Biochem Biophys Res Commun
; 499(2): 120-127, 2018 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29481800
12.
Aberrant regulation of LncRNA TUG1-microRNA-328-3p-SRSF9 mRNA Axis in hepatocellular carcinoma: a promising target for prognosis and therapy.
Mol Cancer
; 21(1): 36, 2022 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35120500
13.
MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.
Mol Cancer
; 16(1): 48, 2017 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28241827
14.
Role of GPR30 in estrogen-induced prostate epithelial apoptosis and benign prostatic hyperplasia.
Biochem Biophys Res Commun
; 487(3): 517-524, 2017 06 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28412354
15.
[Correlation of oxidative stress with sperm DNA integrity and semen parameters in infertile men with varicocele].
Zhonghua Nan Ke Xue
; 22(6): 530-533, 2016 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-28963843
16.
Autophagy defects suggested by low levels of autophagy activator MAP1S and high levels of autophagy inhibitor LRPPRC predict poor prognosis of prostate cancer patients.
Mol Carcinog
; 54(10): 1194-204, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25043940
17.
MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancer.
Tumour Biol
; 36(3): 1983-91, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25394900
18.
[Association of BCL9 expression with prostate cancer clinicopathological features and survival].
Zhonghua Yi Xue Za Zhi
; 95(32): 2603-6, 2015 Aug 25.
Artículo
en Zh
| MEDLINE | ID: mdl-26711608
19.
MicroRNA-224 inhibits progression of human prostate cancer by downregulating TRIB1.
Int J Cancer
; 135(3): 541-50, 2014 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24382668
20.
Elevated levels of mitochondrion-associated autophagy inhibitor LRPPRC are associated with poor prognosis in patients with prostate cancer.
Cancer
; 120(8): 1228-36, 2014 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24390809